Published in J Natl Cancer Inst on November 02, 1994
Determination of specific radioactivities of mononucleotides and glycolytic intermediates from mouse liver after labelling in vivo with [32P]orthophosphate. Eur J Biochem (1968) 0.89
Sound, shock waves shatter kidney stones. JAMA (1983) 0.81
Time of truth for cancer vaccines. J Natl Cancer Inst (1994) 0.78
Glycosylphosphatidylinositol-specific phospholipase D of human serum--activity modulation by naturally occurring amphiphiles. Biol Chem (2000) 0.77
Premenstrual syndromes, depression linked. JAMA (1983) 0.77
Hippocratic oath versus managed care: physicians caught in ethical squeeze. J Natl Cancer Inst (1997) 0.77
Investigators seek to increase taxol supply. J Natl Cancer Inst (1989) 0.77
Sex after chemo: a neglected issue. J Natl Cancer Inst (1993) 0.77
Researchers gain footholds in the cell cycle. J Natl Cancer Inst (1995) 0.77
Street drugs yield primate Parkinson's model. JAMA (1983) 0.76
A switch in time saves a statistical bind. JAMA (1991) 0.75
Keeping cells in their place: the role of tumor suppressor genes. J Natl Cancer Inst (1989) 0.75
Tumor virologists' reunion recalls century of research. J Natl Cancer Inst (1992) 0.75
1971-1991: virus cancer research pays rich dividends. J Natl Cancer Inst (1991) 0.75
FDA approval is not the end: getting the most out of taxol. J Natl Cancer Inst (1993) 0.75
Secondary leukemias receive increased attention. J Natl Cancer Inst (1995) 0.75
Gene therapy centers poised to proliferate. J Natl Cancer Inst (1994) 0.75
Panel concludes ovarian cancer screening benefit unproven. J Natl Cancer Inst (1994) 0.75
NCI scientist "temping" in top genome post. J Natl Cancer Inst (1992) 0.75
p53: how a tumor suppressor works. J Natl Cancer Inst (1991) 0.75
Drug designers target Ras for cancer treatment. J Natl Cancer Inst (1993) 0.75
Amnesic patients give clues on structure of memory. JAMA (1983) 0.75
Cefamandole concentrations in pulmonary and subcutaneous tissue. J Antimicrob Chemother (1979) 0.75
Elderly patient needs assessment, not neglect. JAMA (1983) 0.75
NIH launches human genome effort. J Natl Cancer Inst (1988) 0.75
Gene transfer trial approved. J Natl Cancer Inst (1989) 0.75
Smoking control effort moves to second phase. J Natl Cancer Inst (1993) 0.75
Scientists adapt to loss of mice at Jackson Lab. J Natl Cancer Inst (1989) 0.75
A review: new discoveries allow oncogenes to reclaim limelight. J Natl Cancer Inst (1989) 0.75
Hormone replacement therapy: some answers ... more questions. J Natl Cancer Inst (1992) 0.75
Cancer vaccines: researchers seek to turn promise into practice. J Natl Cancer Inst (1990) 0.75
AACR president assesses state of cancer research. J Natl Cancer Inst (1994) 0.75
Twenty years of progress in immunology research is ready for harvest. J Natl Cancer Inst (1991) 0.75
The trials of olestra: is a fat-free lunch too costly? J Natl Cancer Inst (1995) 0.75
Promising agents for limiting renal damage. JAMA (1983) 0.75
Too many breast biopsies? Watching vs. cutting. J Natl Cancer Inst (1991) 0.75
Collins takes helm of NIH genome project. J Natl Cancer Inst (1993) 0.75
Scientists gain insight into cancer gene relationships. J Natl Cancer Inst (1993) 0.75
Ambulatory dialysis: special boon for children. JAMA (1983) 0.75
Experts mull testing guidelines for family cancers. J Natl Cancer Inst (1991) 0.75
Oncogene links seen to heart disease, cholesterol. J Natl Cancer Inst (1989) 0.75
More patients to receive taxol. J Natl Cancer Inst (1992) 0.75
'Tricks' of trade aid kidney transplants. JAMA (1983) 0.75
When molecules tell tales, cancer researchers listen. J Natl Cancer Inst (1994) 0.75
Government moves to increase taxol supply. J Natl Cancer Inst (1991) 0.75
Scientists, activists discuss DES issues. J Natl Cancer Inst (1992) 0.75
Agreement to develop Taxotere expected in April. J Natl Cancer Inst (1992) 0.75
Cancer genes pose new dilemmas. J Natl Cancer Inst (1994) 0.75
Researchers getting tough with pain. J Natl Cancer Inst (1994) 0.75
Perspective: what makes a cell run wild? J Natl Cancer Inst (1989) 0.75
Palliation may block cure of incontinence in elderly. JAMA (1983) 0.75
Hormone replacement grows; some experts worried. J Natl Cancer Inst (1996) 0.75
Investigators, insurers consider marrow transplant issues. J Natl Cancer Inst (1991) 0.75
New clinical trials under way for DCIS. J Natl Cancer Inst (1997) 0.75
Doctors strive to minimize DCIS treatment. J Natl Cancer Inst (1997) 0.75
Dangers seen in increased treatment of elderly. J Natl Cancer Inst (1992) 0.75
Gel chromatographic characterization of the hydrophobic interaction of glycosylphosphatidylinositol-alkaline phosphatase with detergents. Biol Chem (2000) 0.75
Cutting edge meets clinic in treatment research. J Natl Cancer Inst (1994) 0.75
1971-1991: molecular oncology comes into its own. J Natl Cancer Inst (1991) 0.75
Wing of fly, gene of worm: unusual models shed light on cancer. J Natl Cancer Inst (1993) 0.75
NCI awards Jackson Lab $9.5 million to rebuild. J Natl Cancer Inst (1990) 0.75